Do lower eGFR and higher serum creatinine indicate reduced kidney filtration and do mild eGFR reductions increase cardiovascular risk?

Estimated glomerular filtration rate (eGFR) and serum creatinine are the standard clinical markers for assessing renal filtration capacity, with declines in these metrics closely tied to systemic vascular health.

Diagnostic accuracy and physiological determinants

• Kidney Filtration Markers: Under international KDIGO guidelines, lower eGFR and higher serum creatinine directly indicate reduced kidney filtration capacity.
• Non-Filtration Influences: Because creatinine is a muscle waste product, serum levels are heavily modulated by non-filtration determinants. High muscle mass and elevated dietary protein or cooked meat intake raise serum creatinine, which can artificially lower eGFR, while low muscle mass can mask renal impairment.

Cardiovascular risk at mild eGFR reductions

• Relative Risk Escalation: Mild eGFR reductions (60–89 mL/min/1.73 m² or below age-specific norms) are independently associated with elevated cardiovascular disease (CVD) risk, even before traditional diagnostic thresholds for chronic kidney disease are met.
• Cohort Metrics: An Ontario population-based cohort of 8.7 million adults demonstrated that modest eGFR declines (70–80 mL/min/1.73 m²) carry a ~40% relative increase in composite major adverse clinical outcomes, largely driven by cardiovascular events.
• Atherosclerosis and Graded Risk: The Framingham Offspring Study linked mild reductions (60–69 mL/min/1.73 m²) to subclinical atherosclerosis. CKD Prognosis Consortium data confirm a graded, progressive rise in cardiovascular events starting below 75–90 mL/min/1.73 m², which acts additively with albuminuria to compound cardiovascular risk.

Bottom line

• Even mild reductions in eGFR (60–89 mL/min/1.73 m²) are robust, independent predictors of subclinical atherosclerosis and cardiovascular mortality. Clinical evaluation—especially in younger individuals—should contextualize creatinine-based eGFR alongside muscle mass, protein intake, and albuminuria, or utilize alternative markers like cystatin C for precise risk stratification.